Canadian Banks Lead Recent Earnings Season: RY Stands Out With 10.2% EPS Growth

As of early March 2026, financial markets are digesting a wave of earnings releases from late February, with Royal Bank Of Canada emerging as a standout performer among major North American financial institutions. The Canadian banking sector took center stage with three major lenders reporting their quarterly results simultaneously, setting the tone for the broader earnings cycle.

Royal Bank Of Canada posted quarterly results for the period ending January 31, 2026, with analysts forecasting earnings per share of $2.81, representing a robust 10.2% year-over-year increase. However, the bank faced challenges in the previous year’s second quarter, where it fell short of expectations by 2.22%. The valuation story becomes more compelling when examining Zacks metrics: RY’s 2026 P/E ratio stands at 14.92, compared to the banking industry average of 12.10—a gap suggesting stronger growth potential relative to sector peers.

When Canadian Banking Giants Report Together: Sector-Wide Momentum

Toronto Dominion Bank and Canadian Imperial Bank of Commerce, reporting for the same quarterly period ending January 31, 2026, painted a picture of consistent outperformance within the Canadian financial system. TD’s expected EPS reached $1.63, marking a 17.27% surge from the year-ago quarter—notably exceeding RY’s growth rate. The bank’s track record proves compelling: TD has beaten analyst expectations in every quarter over the past twelve months, with its strongest beat arriving in Q4 2025 when results topped forecasts by 6.85%.

CM delivered an expected EPS of $1.74, reflecting a 12.26% increase year-over-year, while similarly maintaining a perfect streak of quarterly beats. The two institutions’ consistent outperformance underscores the strength of Canada’s banking sector. From a valuation perspective, TD trades at a 14.17 P/E (vs. 12.10 industry average) and CM at 14.02, both suggesting premium positioning relative to broader banking competitors.

Beyond Banking: A Mixed Picture Across Diversified Sectors

While Canadian banks dominated the February filing calendar, other industry segments showed more divergent patterns. Warner Bros. Discovery, the broadcast and media company, surprised with a 110% EPS surge to $0.02 for its December 2025 quarter—though this recovery should be contextualized within the company’s elevated 71.10 P/E ratio versus a 6.10 industry benchmark, hinting at market expectations for sustained improvements.

Energy and utilities presented a more nuanced narrative. Sempra’s expected EPS of $1.13 reflected a 24.67% decline versus the prior-year quarter, while Vistra Corp. posted a dramatic 120.18% EPS increase to $2.51. Vistra’s outsized growth masked underlying volatility, having missed Q4 2024 expectations by 47.47%. Public Service Enterprise Group and Cheniere Energy both signaled headwinds, with PEG’s EPS forecast down 15.48% and LNG’s down 11.55%.

Biotech and Healthcare Show Explosive Growth Trajectories

The pharmaceutical and biomedical sectors displayed the most dramatic earnings swings. argenx SE reported expected EPS of $6.24, translating to a staggering 294.94% year-over-year increase, though the company had previously missed Q4 2024 consensus by 13.66%. BeOne Medicines Ltd. projected EPS of $1.60, reflecting a 211.89% surge—testament to accelerating momentum in the gene therapy and advanced medicine space, with valuations reflecting premium positioning at 112.16 P/E versus negative industry averages.

Valuation Snapshots: When Price-to-Earnings Ratios Tell the Story

Zacks Investment Research data reveals a critical pattern: companies outpacing their industry P/E benchmarks generally signal stronger prospective earnings growth. RY’s 2.82-point premium over the 12.10 banking average, combined with its positive 10.2% EPS outlook, exemplifies this dynamic. Similarly, EMCOR Group, the building services firm, delivered a modest 5.7% EPS increase to $6.68 while trading at 31.95 P/E—below the industry average of 57.20, suggesting potential undervaluation.

Tech and internet services represented another interesting study. Baidu’s expected EPS of $1.12 dropped 49.55% from the prior year, yet the company maintained a perfect streak of quarterly beats, with a particularly impressive 35.16% beat in Q3 2025. Trading at 21.94 P/E versus a negative -1.90 industry average signals investor confidence despite recent earnings deceleration.

The Broader Takeaway: Sector Rotation and Earnings Resilience

The February 2026 earnings cycle underscored the divergence between old-guard financials and growth-oriented biotech and energy transformation plays. RY and its Canadian peer banks demonstrated the enduring appeal of traditional financial services when earnings growth exceeds expectations. Meanwhile, the explosive beats in biomedical and energy transition stocks—despite higher valuations—suggest investors remain bullish on structural industry shifts.

For those tracking earnings season momentum, three observations stand out: First, Canadian banks including RY continue delivering steady, above-forecast performance. Second, valuations increasingly reflect sector rotation, with premium multiples concentrated in growth areas like biotech. Third, even mature companies like Baidu can maintain investor enthusiasm through consistent beat records, regardless of year-over-year percentage declines. As additional companies report through the cycle, watching which firms navigate expectations and which disappoint will prove critical to understanding market positioning heading into spring.